We're here for you if you want to talk

0808 2080 888

[email protected]

Our funding schemes

Our current schemes provide funding for laboratory-based research projects and clinical trials.

Research projects

Applications to the following schemes are considered by our Research Committee.

Project grants - call for applications

Project grants are awarded for up to £250,000 and up to three years for clearly defined research projects addressing key questions in the field of blood cancer. The remit of the project grant scheme includes research projects that maximise the value and outcome of a clinical trial and specifically includes applications that would previously have been considered through the Trial-Associated Research Project scheme. Please note that new applications for biobank funding will not be considered.

All applications must be submitted via Grant Tracker.

The most recent project funding round opened on 18 May 2020 with a deadline of 3 September 2020. Outcomes will be known in March 2021.

Blood Cancer UK is currently undertaking a review of its research priorities for the next five years. This work is due to be completed in April 2021 with details of new funding rounds and grant application deadlines to be announced in early summer 2021.

If you have grant application queries, please contact the research team at [email protected]

Programme Continuity grants

Current or recent holders of Blood Cancer UK Programme grants can apply for support to maintain core elements of their research programme, including but not limited to the retention of key research personnel. The purpose of this funding scheme is to allow successful applicants to maintain a strong blood cancer focus to their work, while maximising investment from other funders.

Funding is available for up to £300,000 for up to 3 years. Potential applicants must discuss an application with ou Research Team before they can begin an application in Grant Tracker.

All applications must be submitted via Grant Tracker.

The most recent Programme Continuity funding round opened on 18 May 2020 with a deadline for applications of 3 September 2020. Outcomes will be known in March 2021. 

For further enquiries, please contact the research team at [email protected].

Please read the Programme continuity guidance document before submitting an application.

Clinical trials

Applications to the following scheme are considered by our Clinical Trials Committee.

Early Phase Clinical Trial grants – call for applications

This scheme provides up to £400,000 of funding to support early phase academic trials to evaluate blood cancer treatments, with the aim of funding research which translates into further studies to evaluate clinical efficacy. Applications are expected to be developed with the involvement of a relevant clinical trials unit.

The first funding round for this scheme was closed in February 2020, with applications reviewed by the Clinical Trials Committee in October 2020. At present there are no open funding rounds for this grant scheme.

All applications must be submitted via Grant Tracker.

Please read the Early Phase Clinical Trials guidance document before submitting an application.

Trial-Associated Research Projects

Applications requesting support for laboratory-based research projects that are integral to clinical trials and essential for the analysis of primary and/or secondary end points and clinical outcome can be submitted through our standard project grant scheme and will be considered by our Research Committee.

Training and career development awards

Training and career development award applications are considered by our Training and Career Development sub-Committee, which makes funding recommendations to our Research Committee.

Previous schemes included Gordon Piller PhD studentships, Bennett fellowships for post-doctoral researchers, Clinical Research Training fellowships for haematologists training for a PhD and Lectureships.

At present there are no open rounds for this committee.